Bactrim
Bactrim is a pharmaceutical drug with 7 clinical trials. Currently 1 active trials ongoing. Historical success rate of 60.0%.
Success Metrics
Based on 3 completed trials
Phase Distribution
Phase Distribution
1
Early Stage
2
Mid Stage
2
Late Stage
Highest Phase Reached
Phase 3Trial Status & Enrollment
60.0%
3 of 5 finished
40.0%
2 ended early
1
trials recruiting
7
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Collaborative Urological Prosthetics Investigation Directive Research Group
Or v IV Antibiotics for Infection
Prevention of Catheter-Associated Urinary Tract Infection in Incontinence and Reconstructive Pelvic Surgery Patients
Pediatric Kidney Transplant Without Calcineurin Inhibitors
Steroid Withdrawal in Pediatric Kidney Transplant Recipients
Clinical Trials (7)
Collaborative Urological Prosthetics Investigation Directive Research Group
Or v IV Antibiotics for Infection
Prevention of Catheter-Associated Urinary Tract Infection in Incontinence and Reconstructive Pelvic Surgery Patients
Pediatric Kidney Transplant Without Calcineurin Inhibitors
Steroid Withdrawal in Pediatric Kidney Transplant Recipients
S0333 Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
Prospective Randomized Trial of Bactrim on 7 Day Outcome in Patients With Uncomplicated Abscesses
All 7 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 7